Cargando…
PSUN145 Nursing Perception of Implementation of Continuous Glucose Monitoring Technology in Patients with Hyperglycemia During the COVID-19 Pandemic
INTRODUCTION: During the COVID-19 pandemic, the FDA began allowing hospitals to use continuous glucose monitoring (CGM) on a "non-objection" basis in the inpatient setting to decrease direct patient contact and preserve personal protective equipment while increasing the availability of glu...
Autores principales: | Talley, Paula, Wood, Jessica, Turner-Sotelo, Kelly, Lozada, Alejandra, Le, Trang, Celi, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624815/ http://dx.doi.org/10.1210/jendso/bvac150.757 |
Ejemplares similares
-
PSUN224 Resident Education for Improved Quality and Confidence in Inpatient Hyperglycemia Management
por: Horowitz, Maxwell, et al.
Publicado: (2022) -
PSUN239 Severe Insulin Resistance and Hyperglycemia with Mild COVID-19 Infection
por: Azmath, Misbah, et al.
Publicado: (2022) -
PSUN272 Opportunity for Inpatient Use of Continuous Glucose Monitoring: A Case Report of Acute Pancreatitis Secondary to Hypertriglyceridemia
por: Romo, Karina G, et al.
Publicado: (2022) -
PSUN166 Triglycerides and Glucose Index as a Predictor of Renal Impairment
por: Lee, Seung Eun, et al.
Publicado: (2022) -
PSUN140 “Awakening of the Beta Cell(©)”
por: Jasper, Josephine, et al.
Publicado: (2022)